Outcomes from low-risk ductal carcinoma in situ: a systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2024 at "Breast Cancer Research and Treatment"
DOI: 10.1007/s10549-024-07473-w
Abstract: The current standard of treatment for ductal carcinoma in situ (DCIS) is surgery with or without adjuvant radiotherapy. With a growing debate about overdiagnosis and overtreatment of low-risk DCIS, active surveillance is being explored in… read more here.
Keywords: risk dcis; ductal carcinoma; review; low risk ... See more keywords
Abstract P6-16-02: Cost-effectiveness of endocrine therapy or radiation treatment alone or in combination for standard- and good-risk DCIS
Sign Up to like & getrecommendations! Published in 2020 at "Cancer Research"
DOI: 10.1158/1538-7445.sabcs19-p6-16-02
Abstract: Introduction: Ductal carcinoma in situ (DCIS) accounts for 20% of breast cancer cases in the United States and is potentially overtreated leading to high expenditures and low-value care. We conducted a first-of-its-kind cost-effectiveness analysis evaluating… read more here.
Keywords: risk; risk dcis; treatment; good risk ... See more keywords
Abstract GS2-06: Patient Reported Outcomes Following Active Monitoring or Surgery (+/- Radiation) for Low Risk DCIS in the Comparing an Operation to Monitoring, with or without Endocrine Therapy (COMET) Study (AFT-25)
Sign Up to like & getrecommendations! Published in 2025 at "Clinical Cancer Research"
DOI: 10.1158/1557-3265.sabcs24-gs2-06
Abstract: Background: Data comparing patient-reported outcomes (PROs) comparing management strategies for low-risk ductal carcinoma in situ (DCIS) are lacking. Comparing an Operation to Monitoring, with or without Endocrine Therapy (COMET), for low-risk DCIS is a prospective… read more here.
Keywords: cancer; risk dcis; monitoring; low risk ... See more keywords